JWH-073
From Wikipedia, the free encyclopedia
|
JWH-073
|
|
| Systematic (IUPAC) name | |
| naphthalen-1-yl-(1-butylindol-3-yl)methanone | |
| Identifiers | |
| CAS number | ? |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C23H21NO |
| Mol. mass | 327.42 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status |
Legal |
| Routes | ? |
JWH-073 is an analgesic drug from the aminoalkylindole family, which acts as a cannabinoid agonist at both the CB1 and CB2 receptors. It is somewhat selective for the CB1 subtype, with affinity at this subtype approximately 5x the affinity at CB2.[1] The abbreviation JWH stands for John W. Huffman, one of the inventors of the compound.
[edit] References
- ^ Aung MM, Griffin G, Huffman JW, et al (August 2000). "Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB(1) and CB(2) receptor binding". Drug Alcohol Depend 60 (2): 133–40. doi:. PMID 10940540.
|
|||||||||||||||||||||||||||||||||||||

